Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
ClinicalTrials.gov study NCT04629209. IPD Sharing: NO. Countries: 1. Publications: 0.
Best EGFR-TKI Sequence in NSCLC Harboring EGFR Mutations
ClinicalTrials.gov study NCT04811001. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy
ClinicalTrials.gov study NCT06156878. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lazertinib and Chemotherapy Combination in EGFR-mutant NSCLC Patients Without ctDNA Clearance After lead-in Lazertinib Monotherapy
ClinicalTrials.gov study NCT06020989. IPD Sharing: NO. Countries: 1. Publications: 0.
JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations
ClinicalTrials.gov study NCT06391944. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation
ClinicalTrials.gov study NCT04233021. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07054307. IPD Sharing: NO. Countries: 0. Publications: 0.
EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer Harboring Activating EGFR Mutations
ClinicalTrials.gov study NCT03516214. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
HLX07(Anti-EGFR mAb) in Patients With Advanced or Metastatic Solid Tumors
ClinicalTrials.gov study NCT05360368. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Tivantinib (ARQ 197) Plus Cetuximab in EGFR Inhibitor-Resistant MET High Subjects
ClinicalTrials.gov study NCT01892527. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.
ClinicalTrials.gov study NCT01525199. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced
ClinicalTrials.gov study NCT01153399. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Correlation Between Estimated Glomerular Filtration Rate(eGFR) and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)
ClinicalTrials.gov study NCT02394743. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance
ClinicalTrials.gov study NCT02930954. IPD Sharing: YES. Countries: 1. Publications: 0.
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC
ClinicalTrials.gov study NCT03389256. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth
ClinicalTrials.gov study NCT05364073. IPD Sharing: NO. Countries: 11. Publications: 0.
RT Plus EGFR-TKI for Wild-type NSCLC
ClinicalTrials.gov study NCT02738983. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
EGFR Monoclonal Antibody for Advanced Gastric Cancer
ClinicalTrials.gov study NCT04136600. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of the Response to Tyrosine Kinase Inhibitors in Localized Non-small Cell Lung Cancer (NSCLC) Patients With EGFR Mutation in a Patient-derived Organoid Model
ClinicalTrials.gov study NCT05136014. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tailored Second Line Treatment by Epidermal Growth Factor Receptor (EGFR) Mutation in Patients With Advanced Lung Adenocarcinoma
ClinicalTrials.gov study NCT00903292. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.